Press Release: Evolent : Evolent Announces Fourth Quarter and Full Year 2024 Results
Revenue of $646.5 million for the three months ended December 31, 2024 and $2,554.7 million for the year ended December 31, 2024, representing 16.3% and 30.1%...
Read full article »
Evolent is a Virginia-based SaaS platform that offers solutions such as genetic testing, care management, and administration for the healthcare industry.
Read more